Blood-brain barrier dysfunction and recovery after ischemic stroke

X Jiang, AV Andjelkovic, L Zhu, T Yang… - Progress in …, 2018 - Elsevier
The blood-brain barrier (BBB) plays a vital role in regulating the trafficking of fluid, solutes
and cells at the blood-brain interface and maintaining the homeostatic microenvironment of …

[HTML][HTML] Magnetic iron oxide nanoparticles for imaging, targeting and treatment of primary and metastatic tumors of the brain

LL Israel, A Galstyan, E Holler, JY Ljubimova - Journal of Controlled …, 2020 - Elsevier
Magnetic nanoparticles in general, and iron oxide nanoparticles in particular, have been
studied extensively during the past 20 years for numerous biomedical applications. The …

[HTML][HTML] Blood-brain barrier leakage in Alzheimer's disease: From discovery to clinical relevance

G Nehra, B Bauer, AMS Hartz - Pharmacology & therapeutics, 2022 - Elsevier
Alzheimer's disease (AD) is the most common form of dementia. AD brain pathology starts
decades before the onset of clinical symptoms. One early pathological hallmark is blood …

Coagulation factor XII in thrombosis and inflammation

C Maas, T Renné - Blood, The Journal of the American Society …, 2018 - ashpublications.org
Combinations of proinflammatory and procoagulant reactions are the unifying principle for a
variety of disorders affecting the cardiovascular system. The factor XII–driven contact system …

Endothelial dysfunction in the brain: setting the stage for stroke and other cerebrovascular complications of COVID-19

M Sashindranath, HH Nandurkar - Stroke, 2021 - Am Heart Assoc
The Coronavirus disease 2019 (COVID)-19 pandemic has already affected millions
worldwide, with a current mortality rate of 2.2%. While it is well-established that severe acute …

The role of plasminogen activators in stroke treatment: fibrinolysis and beyond

AM Thiebaut, M Gauberti, C Ali… - The Lancet …, 2018 - thelancet.com
Although recent technical advances in thrombectomy have revolutionised acute stroke
treatment, prevalence of disability and death related to stroke remain high. Therefore …

Potent Thrombolytic Effect of N-Acetylcysteine on Arterial Thrombi

S Martinez de Lizarrondo, C Gakuba, BA Herbig… - Circulation, 2017 - Am Heart Assoc
Background: Platelet cross-linking during arterial thrombosis involves von Willebrand Factor
(VWF) multimers. Therefore, proteolysis of VWF appears promising to disaggregate platelet …

Non-invasive drug delivery across the blood–brain barrier: a prospective analysis

SK Niazi - Pharmaceutics, 2023 - mdpi.com
Non-invasive drug delivery across the blood–brain barrier (BBB) represents a significant
advancement in treating neurological diseases. The BBB is a tightly packed layer of …

Hemorrhagic blood failure: oxygen debt, coagulopathy, and endothelial damage

NJ White, KR Ward, S Pati, G Strandenes… - Journal of Trauma and …, 2017 - journals.lww.com
Trauma is responsible for 1 in 10 deaths worldwide and is the leading cause of death of
people less than 45 years old. 1 The two most common causes of death in trauma victims …

Thromboinflammation in brain ischemia: recent updates and future perspectives

SF De Meyer, F Langhauser, S Haupeltshofer… - Stroke, 2022 - Am Heart Assoc
Despite decades of promising preclinical validation and clinical translation, ischemic stroke
still remains as one of the leading causes of death and disability worldwide. Within its …